COVID-19 Funding Opportunities

University of Kentucky Internal Pilot Funding

• UK CURE - COVID-19 Pilot Program, Core 3- Social Sciences
• The University of Kentucky Center for Clinical and Translational Sciences - UK CURE COVID-19 Pilot Program
• UK CURE - COVID-19 Pilot Program, Core 2-Materials/Methods

Biomedical Advanced Research and Development Authority (BARDA)

• Special Instructions 009 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002

Centers for Disease Control and Prevention

•  Community Health Workers for COVID Response and Resilient Communities (CCR)- Evaluation and Technical Assistance (ETA) (CDC-RFA-DP21-2110) - Forecasted Opportunity - Estimated Deadline 05/22/2021

Conservation X LAbs

• Notice of Intent to Publish - Microfiber Innovation Challenge - Applications Open 1/27/2021

Department of Commerce / Economic Development Administration

• FY 2020 EDA Public Works and Economic Adjustment Assistance Programs including CARES Act Funding (PWEAA2020)

Department of Defense/MTEC

• Potential Topics of Upcoming Funding Opportunities in 2020
• Medical CBRN Defense Consortium (MCDC) Other Transaction Agreement (OTA) Request for Information (RFI) – CoV Pandemic Response

Department of Health and Human Services
Office of the Assistant Secretary for Health

• SARS-CoV-2 (COVID-19) Program Activities

Emergent Ventures

• Fast Funding for COVID-19 Science - Applications are paused

MERCK KGAA

• Research Grant for Pandemic Preparedness

Multi-Agency - Operation Warp Speed

• Broad Agency Announcement (BAA) Supporting Research for the U.S. Department of Health and Human Services Under Contracts, Other Transaction Agreements and Technology Investment Agreements for the Treatment and Protection from COVID-19- Deadline: 08/01/22.

National Institutes of Health

• Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide (NOT-AI-21-057) Deadline 05/08/24
• Notice of Special Interest (NOSI) to Encourage Administrative Supplement Applications to Investigate COVID-19 Vaccination and Menstruation (Admin Supp Clinical Trial Optional) (NOT-HD-21-035) Deadline 06/18/21
• FDA Notice of Special Interest (NOSI) to add COVID-19 Capacity Building Grants to PAR-18-604 Vet-LIRN Network Capacity-Building Projects (Vet-LIRN)
• Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth - Deadline 05/08/24
• NIDA Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-21-041) - Deadline 03/31/22
• Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional)
• NIH - Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Deadline 12/16/21
•  NIH - Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration Deadline 05/08/23
• NIH - Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: SARS-CoV-2 Recovery Cohort Studies
• PASC Initiative: Clinical Science Core, Data Resource Core, and PASC Biorepository Core OTA-21-015A
• NIH - Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Required)
• NCATS - Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs  (NOT-TR-21-017) Note: Contact Dr. Phil Kern if interested. Expiration Date: 08/17/24
• NIDA - Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
  (NOT-DA-21-018 Expiration Date: 09/08/24
• Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection (NOT-DA-21-011)
• Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) (NOT-DE-21-001)
• Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) (NOT-AG-21-015)
• Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) (NOT-AA-21-001)
• Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases - Deadline 11/19/21

• Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research - Deadline 06/02/23
• Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities - Deadline 01/08/22
• Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection - Deadline 09/08/24
• NIH - Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic - Deadline 05/08/23
• NIH - Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) – PAR-20-229 -Deadline 08/03/22
• NIH - Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) - NHLBI - Expiration date 07/06/24
• NIH - Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 - Expiration date 09/01/21
• Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders - Expiration date 01/08/24
• Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders - Deadline 09/08/22
• NIAID, NIA - Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) - Expiration date 01/13/23
• NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB, Common Fund, NCATS, NIAAA - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) - Expiration date 03/10/23
• NIEHS Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) - Expiration date 10/03/22
• NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCD, NCI, NIDCR -NIH Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) - Expiration date 01/25/22

National Science Foundation

• NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
• Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19U

Simons Foundation Autism Research Initiative (SFARI)

• SFARI - Maternal COVID-19 as Potential Autism Risk Supplements

United Nations Development Programme Centre for Technology, Innovation, and Sustainable Development -

• COVID-19 Detect and Protect Challenge